PERCEPTIVE ADVISORS LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001224962
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2025 · 115 positions · Total reported value $5.30B · Top-10 concentration 40.5% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 65.6% · 18 new · 40 cut · 24 exited
Active Share (vs S&P 500): 99.3% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -8.8% · vs SPY -10.9% · Prev Value $6.30B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -1.6% · vs SPY -3.7% · Latest Value $5.20B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q4 2025 13F filing, PERCEPTIVE ADVISORS LLC disclosed 115 equity positions with a combined reported value of $5.30B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 40.5% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.
The largest disclosed positions as of Q4 2025 were PRAX ($588.30M), RYTM ($272.57M), ASND ($230.60M). By sector, the heaviest allocations are Health Care 79.3%, Industrials 1.3%. Versus the prior quarter, allocation shifted toward Health Care (+5.0pp), Industrials (+1.0pp) and away from Other (-6.2pp).
Versus the prior quarter, PERCEPTIVE ADVISORS LLC opened 18 new positions, trimmed 40 and fully exited 24, a turnover rate of 65.6% of positions. The portfolio's overlap with the prior quarter was 58% of names.
The largest new positions opened in Q4 2025 were XBI ($134.12M), IVVD ($53.81M), DHR ($45.78M).
Of the 24 positions fully exited versus the prior quarter, the largest were MRUS ($127.39M), INSM ($101.11M), VRNA ($55.93M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2025)
- XBI SPDR SERIES TRUST · $134.12M
- IVVD INVIVYD INC · $53.81M
- DHR DANAHER CORP DEL · $45.78M
- CDTX CIDARA THERAPEUTICS INC COM NEW · $36.48M
- IRON DISC MEDICINE INC · $35.79M
- JAZZ JAZZ PHARMACEUTICALS PLC · $28.90M
- PALI PALISADE BIO INC · $28.32M
- AXGN AXOGEN INC · $25.66M
Fully Exited (vs previous quarter)
- MRUS MERUS N V · prev qtr: $127.39M
- INSM INSMED INC · prev qtr: $101.11M
- VRNA VERONA PHARMA PLC · prev qtr: $55.93M
- AKRO AKERO THERAPEUTICS INC · prev qtr: $53.93M
- JANX JANUX THERAPEUTICS INC · prev qtr: $7.15M
- TEM TEMPUS AI INC · prev qtr: $6.86M
- HTFL HEARTFLOW INC · prev qtr: $5.05M
- SCPH SCPHARMACEUTICALS INC · prev qtr: $3.31M
Insider Transactions (Form 4)
Latest PERCEPTIVE ADVISORS LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
| Transaction date | Activity | Security | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-10-26 | Opt exercise | LeonaBio, Inc. | 776,648 | $0.00 | SEC filing |
| 2026-08-26 | Buy | Immatics N.V. | 863,060 | $8.69 | SEC filing |
| 2026-07-20 | Award | Freenome, Inc. | 5,500,000 | $10.00 | SEC filing |
| 2026-06-17 | Award | Kardigan, Inc. | 20,706 | — | SEC filing |
| 2026-04-17 | Award | MeiraGTx Holdings plc | 555,555 | $9.00 | SEC filing |
Fund Profile
Perceptive Advisors is an SEC-registered 13F filer based in New York, NY, United States. As of Q3 2026 it reported 101 US equity positions with a combined value of $5.20B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-71841 (status: Approved), registered 2010-10-04
- Regulatory AUM (Form ADV): $11.77B as of 2026-07-13
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 17 private funds, of which 6 hedge funds
Portfolio Structure
- 101 positions · $5.20B reported value (Q3 2026)
- Top 10 holdings = 53.5% of reported value
- Largest position: PRAX (PRAXIS PRECISION MEDICINES I) at 11.3%
- Average position size: $51.53M
Sector Tilt
- Health Care 94.4%
- Industrials 1.8%
- Financials 0.0%
- (classified holdings cover 96% of value)
Quarterly Activity
- Q3 2026: 18 new, 15 added, 40 reduced, 24 exited
- 28 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
2.00M | $588.30M | 11.11% | Add | |
| 2 |
|
2.55M | $272.57M | 5.15% | Reduce | |
| 3 |
|
1.08M | $230.60M | 4.36% | Reduce | |
| 4 |
|
2.33M | $175.92M | 3.32% | Add | |
| 5 |
|
7.99M | $173.28M | 3.27% | Add | |
| 6 |
|
1.67M | $167.49M | 3.16% | Add | |
| 7 |
|
4.28M | $163.47M | 3.09% | Add | |
| 8 |
|
1.10M | $134.12M | 2.53% | New | |
| 9 |
|
1.20M | $121.92M | 2.30% | Add | |
| 10 |
|
1.35M | $117.95M | 2.23% | Add | |
| 11 |
|
1.45M | $114.76M | 2.17% | Add | |
| 12 |
|
4.46M | $110.62M | 2.09% | Add | |
| 13 |
|
10.38M | $109.03M | 2.06% | Add | |
| 14 |
|
3.07M | $100.55M | 1.90% | Add | |
| 15 |
|
8.28M | $100.08M | 1.89% | Reduce | |
| 16 |
|
1.47M | $95.59M | 1.80% | Reduce | |
| 17 |
|
3.04M | $94.69M | 1.79% | Add | |
| 18 |
|
979.00K | $93.35M | 1.76% | Add | |
| 19 |
|
6.37M | $90.72M | 1.71% | Hold | |
| 20 |
|
3.26M | $85.88M | 1.62% | Add | |
| 21 |
|
6.49M | $84.89M | 1.60% | Hold | |
| 22 |
|
10.33M | $82.09M | 1.55% | Reduce | |
| 23 |
|
1.72M | $78.55M | 1.48% | Reduce | |
| 24 |
|
2.92M | $72.97M | 1.38% | Reduce | |
| 25 |
|
3.48M | $68.05M | 1.28% | Add | |
| 26 |
|
3.56M | $67.45M | 1.27% | Add | |
| 27 |
|
11.83M | $66.74M | 1.26% | Hold | |
| 28 |
|
414.24K | $66.26M | 1.25% | Add | |
| 29 |
|
458.34K | $61.81M | 1.17% | Add | |
| 30 |
|
21.79M | $53.81M | 1.02% | New | |
| 31 |
|
5.87M | $53.00M | 1.00% | Add | |
| 32 |
|
315.54K | $51.70M | 0.98% | Add | |
| 33 |
|
1.99M | $50.71M | 0.96% | Add | |
| 34 |
|
87.92K | $49.79M | 0.94% | Add | |
| 35 |
|
1.18M | $48.51M | 0.92% | Hold | |
| 36 |
|
331.05K | $46.95M | 0.89% | Reduce | |
| 37 |
|
200.00K | $45.78M | 0.86% | New | |
| 38 |
|
1.48M | $44.75M | 0.84% | Add | |
| 39 |
|
9.68M | $41.24M | 0.78% | Hold | |
| 40 |
|
2.40M | $37.81M | 0.71% | Hold | |
| 41 |
|
165.13K | $36.48M | 0.69% | New | |
| 42 |
|
450.74K | $35.79M | 0.68% | New | |
| 43 |
|
449.29K | $35.06M | 0.66% | Hold | |
| 44 |
|
110.53K | $34.36M | 0.65% | Reduce | |
| 45 |
|
1.78M | $31.76M | 0.60% | Add | |
| 46 |
|
1.14M | $30.65M | 0.58% | Add | |
| 47 |
|
170.00K | $28.90M | 0.55% | New | |
| 48 |
|
12.05M | $28.32M | 0.54% | New | |
| 49 |
|
825.89K | $27.97M | 0.53% | Add | |
| 50 |
|
266.29K | $27.87M | 0.53% | Reduce | |
FAQ
What did PERCEPTIVE ADVISORS LLC buy in 2025-Q4?
In its 2025-Q4 13F filing, PERCEPTIVE ADVISORS LLC reported 115 equity positions worth $5.30B in aggregate; its largest disclosed positions were PRAX ($588.30M), RYTM ($272.57M), ASND ($230.60M).
How large is PERCEPTIVE ADVISORS LLC's portfolio?
PERCEPTIVE ADVISORS LLC reported $5.30B of long equity holdings across 115 positions as of 2025-Q4. Top-10 holdings account for 40.5% of reported value.
What is PERCEPTIVE ADVISORS LLC's investment style?
HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.